Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials

被引：11
|
作者：
Ali, Suhail M. [1 ,2 ]
Leitzel, Kim [1 ,2 ]
Lipton, Allan [1 ,2 ]
Carney, Walter P. [3 ]
Koestler, Wolfgang J. [4 ]
机构：
[1] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[2] Lebanon VAMC, Lebanon, PA USA
[3] Oncogene Sci Siemens HealthCare Diagnost, Cambridge, MA USA
[4] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 36期
关键词：
METASTATIC BREAST-CANCER; TRASTUZUMAB;
D O I：
10.1200/JCO.2009.23.4674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e273 / e273
页数：1
相关论文
共 50 条
  • [21] RESULTS FROM TWO PHASE 1 TRIALS OF HER2/NEU-DIRECTED ACTIVE CELLULAR IMMUNOTHERAPY IN PATIENTS WITH ADVANCED MALIGNANCIES
    Sims, R. B.
    Park, J. W.
    Peethambaram, P. P.
    Melisko, M.
    Rinn, K. J.
    Alberts, S. R.
    Provost, N. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 99 - 99
  • [22] Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing
    Chung, H.
    Bang, Y. J.
    Xu, J. M.
    Lordick, F.
    Sawaki, A.
    Lipatov, O.
    Lehle, M.
    Pickl, M.
    Rueschoff, J.
    Van Cutsem, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 364 - 364
  • [23] Researchers find discordance between standard human epidermal growth factor receptor 2 (HER2) testing and HER2 status reported on Oncotype DX
    Barton, Mary Kay
    CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (02) : 71 - 72
  • [24] Human epidermal growth factor receptor 2 (HER2) and the future of bladder carcinoma
    Sarkis, Julien
    Alkassis, Marwan
    Assaf, Joy
    ARAB JOURNAL OF UROLOGY, 2020, 18 (04) : 273 - 274
  • [25] Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
    Erickson, Britt K.
    Zeybek, Burak
    Santin, Alessandro D.
    Fader, Amanda N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 57 - 64
  • [26] Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas
    Clauditz, Till Sebastian
    Reiff, Maren
    Gravert, Linn
    Gnoss, Alexander
    Tsourlakis, Maria-Christina
    Muenscher, Adrian
    Sauter, Guido
    Bokemeyer, Carsten
    Knecht, Rainald
    Wilczak, Waldemar
    PATHOLOGY, 2011, 43 (05) : 459 - 464
  • [27] An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
    Elshazly, Ahmed M.
    Gewirtz, David A.
    CANCER DRUG RESISTANCE, 2022, 5 (02) : 472 - 486
  • [28] HER2/neu oncoprotein of human adenocarcinomas: An amplifier of signal transduction by stromal growth factor
    Yarden, Y
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S133 - S133
  • [29] Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
    Shin, Daniel Sanghoon
    Sherry, Timothy
    Kallen, Michael E.
    Wong, Steven
    Drakakia, Alexandra
    CASE REPORTS IN ONCOLOGY, 2016, 9 (02): : 298 - 304
  • [30] Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2)
    van de Vijver, MJ
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S11 - S17
12345